e-learning
resources
Virtual 2020
Wednesday, 09.09.2020
Promising biomarkers for idiopathic interstitial pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biomarkers of collagen formation are predictive of IPF progression and death
N. Hoyer (Copenhagen, Denmark), H. Jessen (Herlev, Denmark), S. Rønnow (Herlev, Denmark), M. Karsdal (Herlev, Denmark), D. Leeming (Herlev, Denmark), J. Sand (Herlev, Denmark), S. Shaker (Copenhagen, Denmark)
Source:
Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Session:
Promising biomarkers for idiopathic interstitial pneumonia
Session type:
Oral Presentation
Number:
5186
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Hoyer (Copenhagen, Denmark), H. Jessen (Herlev, Denmark), S. Rønnow (Herlev, Denmark), M. Karsdal (Herlev, Denmark), D. Leeming (Herlev, Denmark), J. Sand (Herlev, Denmark), S. Shaker (Copenhagen, Denmark). Biomarkers of collagen formation are predictive of IPF progression and death. 5186
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (1) 00074-2016; 10.1183/23120541.00074-2016
Year: 2017
alpha-v-beta-6 integrin may be a potential prognostic biomarker in interstitial lung disease
Source: Eur Respir J 2015; 46: 486-494
Year: 2015
Lung function reversibility as a predictor of disease progression in COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis
Source: Eur Respir J 2016; 48: 1612-1621
Year: 2016
Predicting progression of RA-ILD using anti-CCP
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis
Source: Eur Respir J 2014; 43: 1530-1532
Year: 2014
Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Circulating fibrocytes and collagen turnover products in UIP: marker of disease activity and prognostic tool?
Source: Eur Respir J 2007; 30: Suppl. 51, 118s
Year: 2007
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
Source: ERJ Open Res, 6 (4) 00481-2020; 10.1183/23120541.00481-2020
Year: 2020
Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
The prognostic role of matrix metalloproteinase-7 in scleroderma-associated interstitial lung disease
Source: Eur Respir J, 58 (6) 2101560; 10.1183/13993003.01560-2021
Year: 2021
Extracellular matrix biomarkers predict change in lung function in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020
Inhibition of collagen cross-links by novel LOXL2 selective inhibitors in an in-vitro model of fibroblastic foci of IPF
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Apoptosis, cell proliferation and angiogenesis in progression of different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 573s
Year: 2007
Markers of pulmonary vascular compromise predict survival in interstitial lung disease (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Plasma mitochondrial DNA as a biomarker of disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Defining progression in non-IPF ILD
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept